로딩 중…
지수 로딩 중…
Novo Nordisk A/S
NVO· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
DK
DK$43.19-0.76%
2026-06-18
Price Chart
Novo Nordisk A/S-41.64%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $191.41B |
| Revenue | $49.54B |
| Net Income | $18.43B |
| Total Assets | $87.74B |
| Net Assets | $31.86B |
| Value | |
| P/E | 10.39x |
| P/B | 6.01x |
| PEG | 0.15x |
| P/S | 3.86x |
| EV/EBITDA | 7.69x |
| FCF Yield | 2.45% |
| Profitability | |
| ROE | 57.85% |
| ROA | 21.01% |
| Op. Margin | 45.30% |
| Revenue Growth | 23.99% |
| Earnings Growth | 67.24% |
| Financial Health | |
| Debt Ratio | 175.39% |
| Total Debt | $22.97B |
| FCF | $4.69B |
| Cash | $3.31B |
| Current Ratio | 0.79x |
| Net Debt/EBITDA | 0.72x |
| Dividend | |
| Div. Yield | 4.14% |
| Div. Growth | 17.27% |
| Performance | |
| 1Y Return | -41.64% |
| 1M Return | -2.46% |
| From 52W High | -39.85% |
| 1Y MDD | -56.46% |
| Trading | |
| Volume | 7,981,639 shares |
| Trading Value | $345M |
| Per Share | |
| EPS | $3.29 |
| BPS | $6.24 |